Category: Clinical Breakthroughs
-
Stem Cell Transplants Improve on Current MS Treatments
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
-
Measuring the Overuse of Outpatient Antibiotics
A new study published in The BMJ illustrates the scale of inappropriate antibiotic prescribing in the U.S. outpatient setting, with the most comprehensive estimates to date.
-
Full-Body Scan Could Improve Chemotherapy Effectiveness
A new full-body scan could help clinicians better assess patients during cancer treatment, according to a recent study.
-
Inhaled Nitrite Fails to Show Benefit in Heart Failure; Automated Cardiac Imaging Shows Promise
A treatment of inhaled inorganic nitrite did not improve exercise capacity among patients with a common form of heart failure, according to a clinical trial published in JAMA.
-
Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
-
Drug Regimen Improves Survival in Lymphoma
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
-
Resilience May Be Neurobiological
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
-
Inflammatory Bowel Disease Linked to Prostate Cancer
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
-
World’s Smallest Wearable Device Warns of UV Exposure, Enables Precision Phototherapy
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
-
High Blood Pressure Before Age 40 Linked to Heart Disease
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
